For Hepatocellular Carcinoma Treated with Yttrium-90 Microspheres, Dose Volumetrics on Post-Treatment Bremsstrahlung SPECT/CT Predict Clinical Outcomes

SIMPLE SUMMARY: Transarterial radioembolization (TARE) of the liver with Yttrium-90 (Y-90) microspheres is a prominent approach used to treat hepatocellular carcinoma (HCC), the most common primary liver cancer and the third-leading cause of cancer-related deaths worldwide. Recent studies have found...

Descripción completa

Detalles Bibliográficos
Autores principales: Taswell, Crystal Seldon, Studenski, Matthew, Pennix, Thomas, Stover, Bryan, Georgiou, Mike, Venkat, Shree, Jones, Patricia, Zikria, Joseph, Thornton, Lindsay, Yechieli, Raphael, Mohan, Prasoon, Portelance, Lorraine, Spieler, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913422/
https://www.ncbi.nlm.nih.gov/pubmed/36765603
http://dx.doi.org/10.3390/cancers15030645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913422/
https://www.ncbi.nlm.nih.gov/pubmed/36765603
http://dx.doi.org/10.3390/cancers15030645

Ejemplares similares